Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016

Early influenza vaccine effectiveness results 2015–16: I-MOVE multicentre case-control study

(2016) E Kissling et al.   Eurosurveillance

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15

(2016) Marta Valenciano et al.   Eurosurveillance

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

(2016) Manjusha Gaglani et al.   JOURNAL OF INFECTIOUS DISEASES

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

(2016) Edward A Belongia et al.   LANCET INFECTIOUS DISEASES

Influenza vaccine effectiveness by test-negative design – Comparison of inpatient and outpatient settings

(2016) Shuo Feng et al.   VACCINE

Update: Influenza Activity — United States, October 4, 2015–February 6, 2016

(2016) Kate Russell et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015

(2015) D M Skowronski et al.   Eurosurveillance

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013–2014 Influenza Season

(2015) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

The European I-MOVE Multicentre 2013–2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2)

(2015) Marta Valenciano et al.   VACCINE

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada’s sentinel surveillance network, January 2014

(2014) D Skowronski et al.   Eurosurveillance

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season

(2014) S. L. Linderman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection

(2014) Michelle Tate et al.   Viruses-Basel

The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials

(2013) G De Serres et al.   Eurosurveillance

The case test-negative design for studies of the effectiveness of influenza vaccine

(2013) Ivo M. Foppa et al.   VACCINE

The test-negative design for estimating influenza vaccine effectiveness

(2013) Michael L. Jackson et al.   VACCINE

Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin

(2010) Manabu Igarashi et al.   PLoS One